Decreased 5-hydroxymethylcytosine is associated with neural progenitor phenotype in normal brain and shorter survival in malignant glioma

• Published in: PloS one Vol. 7; no. 7; p. e41036
• Main Authors: Orr, Brent A, Haffner, Michael C, Nelson, William G, Yegnasubramanian, Srinivasan, Eberhart, Charles G
• Format: Journal Article
• Language: English
• Published: United States Public Library of Science 19.07.2012; Public Library of Science (PLoS)
• Subjects: 5-Methylcytosine - analogs & derivatives; Adults; Aggressive behavior; Analysis; Biology; Brain; Brain - cytology; Brain - metabolism; Brain cancer; Brain tumors; Cell Differentiation - physiology; Compartments; Cytosine; Cytosine - analogs & derivatives; Cytosine - metabolism; Deoxyribonucleic acid; DNA; DNA methylation; Enzymes; Epigenetic inheritance; Epigenetics; Fetuses; Gene expression; Genes; Genetic aspects; Glioblastoma; Glioma; Glioma - metabolism; Glioma - mortality; Gliomas; Homeostasis; Humans; Immunohistochemistry; Medicine; Methylation; Mutation; Neurons - cytology; Neurons - metabolism; Progenitor cells; Quality; Stem cells; Stem Cells - cytology; Stem Cells - metabolism; Survival; Tumors; United States > US; Maryland; Baltimore Maryland
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0041036

Epigenetic modification of DNA by cytosine methylation to produce 5-methylcytosine (5mC) has become well-recognized as an important epigenetic process in human health and disease. Recently, further modification of 5mC by the ten eleven translocated (TET) family of enzymes to produce 5-hydroxymethylcytosine (5hmC) has been described. In the present study, we used immunohistochemistry to evaluate the distribution of 5hmC in human brain during different periods of development and in a large series of gliomas (n=225). We found that during development, 5hmC levels are high in more differentiated compartments like the fetal cortex, but low in the periventricular progenitor cell regions. In adults, we found 5hmC levels to be highest in the cortex, but present in all intrinsic cell types in the brain including stromal elements. In brain tumors, 5hmC levels were high in low grade tumors and reduced in malignant glioma, but did not exhibit any correlation with IDH1 mutation status. Additionally, we identified a significant relationship between low levels of 5hmC and reduced survival in malignant glioma. This observation was further supported by in silico analysis showing differential expression of genes involved in 5hmC homeostasis in aggressive subsets of glioblastoma. Finally, we show that several genes involved in regulating the levels of 5hmC are also prognostic in malignant glioma. These findings suggest that 5hmC regulation in malignant glioma may represent an important determinant of tumor differentiation and aggressive behavior, as well as a potential therapeutic target.